New Board of Directors & Executive Committee Members, CEO Tom Sellig
18 Oct 2024 //
PRESS RELEASE
Adare Pharma Solutions Invests $16.8M to Relocate HQ and Upgrade Facilities
20 Sep 2024 //
PRESS RELEASE
Adare Pharma, Laxxon Partner to Advance 3D Printed Oral Dosage Forms
18 Sep 2024 //
PRESS RELEASE
Pennsylvania Governor`s Administration Invests ~$3M to Bring Adare to PA
01 Aug 2024 //
PRESS RELEASE
From Risk To Resolution: A Breakthrough in Nitrosamine Analysis & Mitigation
14 Jun 2024 //
PRESS RELEASE
Adare Expands Global High Potency Handling & Packaging Capabilities
01 May 2024 //
PRESS RELEASE
Adare Pharma Solutions Expanding Oral Dose Capabilities In Europe
12 Mar 2024 //
PRESS RELEASE
Adare Pharma Solutions To Expand Packaging & Warehousing Capabilities In Europe
05 Mar 2024 //
PRESS RELEASE
Adare Pharma Solutions Initiates Expansion of Pessano Facility in Italy
05 Mar 2024 //
PRESS RELEASE
"3 Key Trends" with Srinivasan Shanmugam
28 Sep 2023 //
CONTRACT PHARMA
Adare Pharma Solutions announces divestiture of postbiotics pioneer Adare Biome to dsm-firmenich
03 Jul 2023 //
PRESS RELEASE
DSM Acquires Adare Biome for €275 million
21 Apr 2023 //
CONTRACT PHARMA
Adare Pharma Solutions Selects Vantage to Lead Major Packaging Facility Upgrade
21 Mar 2023 //
PR NEWSWIRE
Adare Partners with Veeva to Strengthen Quality Operations
11 Jan 2023 //
CONTRACTPHARMA
Pharma Supply Chain People Moves
01 Dec 2022 //
CPHI-ONLINE
Tethis appoints Holger Neecke as the company`s Chief Executive Officer
20 Oct 2022 //
PRNEWSWIRE
“3 Key Trends” with Ulrike Foley
12 May 2022 //
CONTRACT PHARMA
Adare Pharma Solutions: Integrated End-To-End CDMO
26 Apr 2022 //
PHARMATECH
Adare Pharma Solutions Appoints Tom Sellig CEO
07 Jan 2022 //
PRESS RELEASE
The Challenges of Formulating Medicines for Children
18 Dec 2021 //
PRESS RELEASE
Adare Pharma Solutions Acquires Frontida BioPharm
01 Dec 2021 //
PRESS RELEASE
Adare Pharma Solutions Expands Executive Leadership Team
27 May 2021 //
PRNEWSWIRE
Adare Pharma Solutions Appoints Ludger Roedder as President, Adare Biome
20 Apr 2021 //
PRESS RELEASE
Fierce Pharma Sits Down With Adare Pharma Solutions
10 Oct 2020 //
FIERCE PHARMA
Thomas H. Lee Partners and Frazier Healthcare Partners Acquire Adare
22 Sep 2020 //
PRESS RELEASE
Adare Pharmaceuticals, Inc. Acquires Orbis Biosciences
04 May 2020 //
BIOSPACE
Adare & NLS Pharmaceutics Collaborate to Develop Mazindol Controlled Release
13 Jan 2020 //
BUSINESSWIRE
VIDEO: Adare Pharmaceuticals` Cheryl Wood
10 Sep 2019 //
CONTRACT PHARMA
Adare acquires Egalet’s proprietary “Parvulet®” technology platform
15 Apr 2019 //
PRESS RELEASE
Lannett enters into distribution agreement with Adare
22 Oct 2018 //
PRESS RELEASE
Adare Licenses Cyclobenzaprine Hydrochloride In Portugal
08 Oct 2018 //
PRESS RELEASE
Adare Pharmaceuticals Announces Changes To Executive Leadership Team
05 May 2018 //
PRESS RELEASE
Pharmaceutical company to expand in Dayton region
01 Sep 2017 //
BIZJOURNALS
John Fraher, CEO of Adare Pharma Named EY Entrepreneur of the Year® 2017
07 Jul 2017 //
BUSINESSWIRE
Adare Pharm’s Generic Potassium Chloride Receives Approval In US
17 Mar 2017 //
FDA
Aptalis Pharma`s Truberzi (Eluxadoline) Approved In Europe
29 Sep 2016 //
EUROPE
Adare Pharmaceuticals Celebrates Corporate Headquarters Grand Opening
28 Sep 2016 //
PRESS RELEASE
Adare Company Spotlight Presentation At Bio International 2016 Convention
06 Jun 2016 //
PRESS RELEASE
Adare Pharmaceuticals Partners with Cincinnati Children’s on Innovation Fund
17 Nov 2015 //
BUSINESSWIRE
Adare Pharmaceuticals Appoints James Jogerst as VP, Corporate Development
05 Oct 2015 //
BUSINESSWIRE
Adare Pharmaappoints Joseph Del Buono As Vice President, Finance And CFO
26 Aug 2015 //
PRESS RELEASE
TPG Completes Acquisition Of Aptalis Pharmaceutical Technologies Summary Adare
01 Apr 2015 //
PRESS RELEASE